Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Cancer research needs a better mapNature (London), 2021-01, Vol.589 (7843), p.514-516 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jan 28, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-00182-0 ;PMID: 33500573Full text available |
|
2 |
Material Type: Article
|
Genetics and Pathogenesis of Diffuse Large B-Cell LymphomaThe New England journal of medicine, 2018-04, Vol.378 (15), p.1396-1407 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;(c) Massachusetts Medical Society, 2018 info:eu-repo/semantics/openAccess ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1801445 ;PMID: 29641966Full text available |
|
3 |
Material Type: Article
|
Targeting ferroptosis as a vulnerability in cancerNature reviews. Cancer, 2022-07, Vol.22 (7), p.381-396 [Peer Reviewed Journal]2022. Springer Nature Limited. ;Springer Nature Limited 2022. ;ISSN: 1474-175X ;EISSN: 1474-1768 ;DOI: 10.1038/s41568-022-00459-0 ;PMID: 35338310Full text available |
|
4 |
Material Type: Article
|
A decade of immune-checkpoint inhibitors in cancer therapyNature communications, 2020-07, Vol.11 (1), p.3801-3801, Article 3801 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-17670-y ;PMID: 32732879Full text available |
|
5 |
Material Type: Article
|
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020-03, Vol.21 (3), p.335-337 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30096-6 ;PMID: 32066541Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory DiseasesBioMed research international, 2016-01, Vol.2016, p.8797206-15 [Peer Reviewed Journal]Copyright © 2016 Elizabeth E. Hull et al. ;COPYRIGHT 2016 Hindawi Limited ;Copyright © 2016 Elizabeth E. Hull et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright © 2016 Elizabeth E. Hull et al. 2016 ;ISSN: 2314-6133 ;EISSN: 2314-6141 ;DOI: 10.1155/2016/8797206 ;PMID: 27556043Full text available |
|
7 |
Material Type: Article
|
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibitedThe Journal of clinical investigation, 2015-03, Vol.125 (3), p.1269-1285 [Peer Reviewed Journal]COPYRIGHT 2015 American Society for Clinical Investigation ;COPYRIGHT 2015 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Mar 2015 ;Copyright © 2015, American Society for Clinical Investigation 2015 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI76452 ;PMID: 25689248Full text available |
|
8 |
Material Type: Article
|
Ferroptosis in cancer therapy: a novel approach to reversing drug resistanceMolecular cancer, 2022-02, Vol.21 (1), p.47-47, Article 47 [Peer Reviewed Journal]2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-022-01530-y ;PMID: 35151318Full text available |
|
9 |
Material Type: Article
|
Oesophageal cancerThe Lancet (British edition), 2017-11, Vol.390 (10110), p.2383-2396 [Peer Reviewed Journal]2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Nov 25, 2017 ;2017. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)31462-9 ;PMID: 28648400Full text available |
|
10 |
Material Type: Article
|
Photodynamic Therapy for Cancer: What's Past is ProloguePhotochemistry and photobiology, 2020-05, Vol.96 (3), p.506-516 [Peer Reviewed Journal]2019 American Society for Photobiology ;2019 American Society for Photobiology. ;Copyright © 2020 American Society for Photobiology ;ISSN: 0031-8655 ;EISSN: 1751-1097 ;DOI: 10.1111/php.13190 ;PMID: 31820824Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
A role for microfluidic systems in precision medicineNature communications, 2022-06, Vol.13 (1), p.3086-3086, Article 3086 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-30384-7 ;PMID: 35654785Full text available |
|
12 |
Material Type: Article
|
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyondNature reviews. Drug discovery, 2019-05, Vol.18 (5), p.379-401 [Peer Reviewed Journal]2019© Springer Nature Limited 2019 ;Springer Nature Limited 2019. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-019-0016-5 ;PMID: 30760888Full text available |
|
13 |
Material Type: Article
|
Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challengesCancer letters, 2020-02, Vol.471, p.61 [Peer Reviewed Journal]2019. Elsevier B.V. ;ISSN: 0304-3835 ;EISSN: 1872-7980 ;DOI: 10.1016/j.canlet.2019.12.007Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Progress and challenges towards targeted delivery of cancer therapeuticsNature communications, 2018-04, Vol.9 (1), p.1410-12, Article 1410 [Peer Reviewed Journal]2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-018-03705-y ;PMID: 29650952Full text available |
|
15 |
Material Type: Article
|
Targeting Tumor-Associated Macrophages in CancerTrends in immunology, 2019-04, Vol.40 (4), p.310 [Peer Reviewed Journal]2019. Elsevier Ltd ;ISSN: 1471-4906 ;EISSN: 1471-4981 ;DOI: 10.1016/j.it.2019.02.003Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Nanomaterial-Enabled Cancer TherapyMolecular therapy, 2017-07, Vol.25 (7), p.1501-1513 [Peer Reviewed Journal]2017 The American Society of Gene and Cell Therapy ;Copyright © 2017 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved. ;2017. The American Society of Gene and Cell Therapy ;2017 The American Society of Gene and Cell Therapy. 2017 The American Society of Gene and Cell Therapy ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2017.04.026 ;PMID: 28532763Full text available |
|
17 |
Material Type: Article
|
Two Hundred Years of Cancer ResearchThe New England journal of medicine, 2012-06, Vol.366 (23), p.2207-2214 [Peer Reviewed Journal]Copyright © 2012 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra1204479 ;PMID: 22646510 ;CODEN: NEJMAGFull text available |
|
18 |
Material Type: Article
|
Researchers revolt against weekend conferencesNature (London), 2023-11, Vol.623 (7989), p.1093-1094 [Peer Reviewed Journal]Copyright Nature Publishing Group Nov 30, 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-023-03430-7Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trialThe Lancet (British edition), 2019-05, Vol.393 (10185), p.2051-2058 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32487-5 ;PMID: 30982687Full text available |
|
20 |
Material Type: Article
|
Fasting and cancer: molecular mechanisms and clinical applicationNature reviews. Cancer, 2018-11, Vol.18 (11), p.707-719 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Nov 2018 ;ISSN: 1474-175X ;EISSN: 1474-1768 ;DOI: 10.1038/s41568-018-0061-0 ;PMID: 30327499Full text available |